Danger Zone Call Featured In Barron’s On 5/7/16

barron's

This past weekend, Barron’s magazine featured our research for the fifth time in 2016 and 21st time since 2014. This time, Barron’s featured our Danger Zone report on Perrigo (PRGO).

Continue Reading →

Featured In Barron’s Over The Weekend

barron's

Over the weekend, Barron’s magazine featured our research for the fourth time in 2016 and 20th time since 2014. This time, Barron’s featured our research on Valeant Pharmaceuticals (VRX).

Continue Reading →

#1 Stock Picker – Value – May 2016

SumZeroRankingsMay_FeatureImage

The latest rankings have been released and New Constructs’ CEO David Trainer is May’s #1 ranked “Value” stock picker per SumZero Rankings

Continue Reading →

#2 Stock Picker – Last Twelve Months – May 2016

SumZeroRankingsLTM_featureimage

The latest rankings have been released and New Constructs’ CEO David Trainer is May’s #2 ranked stock picker over the last twelve months (LTM) per SumZero Rankings.

Continue Reading →

Open Letter To Norway’s Sovereign Wealth Fund: Target Lions Gate Entertainment (LGF)

OpenLetter_NorwaySovereignFund_featureimage

Norway’s Sovereign Wealth Fund announced that it is looking to restructure compensations plans at certain companies in its portfolio. As the fund looks for a company it can target, we offer a candidate: Lions Gate Entertainment (LGF).

Continue Reading →

Identifying Good And Bad Activist Investors

IdentifyActivist_featureimage

There are some genuinely good examples of shareholder activism out there. In the right context, activist investors hold management accountable and play a beneficial role in the market by ensuring that poor corporate governance and strategy don’t persist.

Continue Reading →

The SEC Is Starting To Worry About Non-GAAP Earnings

SECworryNonGAAP_featureimage

We’ve been sounding the alarm on non-GAAP earnings for several years now. Companies exploited the wide leeway granted by the SEC to present their business in a more favorable light.

Continue Reading →

New Constructs #1 Stock Picker – April 2016

Sumzero April rankings_featureimage

The latest rankings are out and New Constructs’ CEO David Trainer is April’s #1 ranked stock picker over the last twelve months (LTM) per SumZero Rankings.

Continue Reading →

The Value Of Transparency: Why Methodology Matters

valuetransparency_featureimage

investors always need to dig deeper than looking at a simple “buy” or “sell”. Sometimes, these ratings can be driven by factors that have nothing to do with markets or fundamentals. On other occasions, the argument might sound convincing but completely crumble when you examine some of the underlying assumptions.

Continue Reading →

#1 Ranked Stock Picker By SumZero

SumZero1Rankings_featureimage1

We are proud to announce that New Constructs has been ranked the #1 LTM Analyst per SumZero Rankings.

Continue Reading →

SumZero Features New Constructs Research

Sumzero-Logo

On Tuesday (3/15/16) SumZero prominently featured our research on Valeant Pharmaceuticals (VRX) as the stock dropped over 50% in one day

Continue Reading →

Danger Zone Call Featured In Barron’s On 3/12/16

barron's

This past weekend, Barron’s magazine featured our research for the third time in 2016 and 19th time since 2014. This time, Barron’s featured research from our Danger Zone report on Zillow Group (ZG).

Continue Reading →

Danger Zone Call Featured In SumZero Face Off

Sumzero-Logo

SumZero featured our analysis on the multitude of issues facing Valeant Pharmaceuticals (VRX).

Continue Reading →

How EV/EBITDA Misses The Point On Valuation

EV_EBITDA_featureimage

In reality, EV/EBITDA can actually be significantly worse than P/E or P/B ratios because EBITDA ignores certain real costs of doing business like taxes, depreciation, and amortization. Put simply, EBITDA is even farther removed from the real cash flows of the business than EPS or net income.

Continue Reading →

Why Investors Need Independent Research

IndependentResearch_featureimage

Some of the best research in the world comes from Wall Street. It has long been a leader in providing investors with ideas and strategies for investing. At the same time, it is important not to paint all Wall Street research with the same brush. Not all of Wall Street is the same, and some of the research it produces poses certain risks.

Continue Reading →

Market Outlook For 2016

marketoutlook_featureimage

I think we are seeing the start of that process in late 2015 and early 2016. The combination of a slowdown in China, falling energy prices, and the end of zero interest rate policy from the Fed have put markets and the global economy in an interesting state of transition.

Continue Reading →

How Buybacks Destroy Shareholder Value

buybacksdestroy_featureimage

Corporate America has the resources to deploy a large amount of capital and invest in new technologies and innovations that can drive growth. Instead, they just keep spending more and more money on buybacks.

Continue Reading →

Danger Zone Call Featured In Barron’s This Past Weekend

barron's

This past weekend, Barron’s magazine featured our research for the second time in 2016 and 18th time since 2014. This time, Barron’s featured research from our Danger Zone report, and recent price update on LinkedIn (LNKD).

Continue Reading →

ROIC: The Paradigm For Linking Corporate Performance To Valuation

paradigmlinkingvaluation_featureimage

It’s incredible that corporate executives and the market as a whole continue to depend on such flawed numbers when we already have a measure that is clearly linked with value creation: return on invested capital (ROIC).

Continue Reading →

If ROIC Is So Great, Then Why Doesn’t Everyone Use It?

MetricWars_featureimage

Why do investors, executives, and the financial media focus on reported earnings and other metrics such as EBITDA that ignore the balance sheet? Why aren’t executives around the world adopting ROIC in order to boost returns?

Continue Reading →

Page 1 of 8